Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial.

However, in contrast to those results, and likely due to the limited power in the GAD subcohort, the effects for bupropion (OR = 2.43; 95% CI = 0.57–10.31) and for NRT (OR= 2.44; 95% CI = 0.58–10.34) versus placebo did not reach statistical significance in these smaller samples.

also in 111,027 other papers